Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) FCF Margin (2018 - 2025)

Bicycle Therapeutics' FCF Margin history spans 8 years, with the latest figure at 41.54% for Q4 2025.

  • For Q4 2025, FCF Margin rose 22178.0% year-over-year to 41.54%; the TTM value through Dec 2025 reached 347.21%, up 28755.0%, while the annual FY2025 figure was 347.21%, 12326.0% up from the prior year.
  • FCF Margin reached 41.54% in Q4 2025 per BCYC's latest filing, up from 612.3% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 497.32% in Q3 2021 to a low of 2509.73% in Q2 2025.
  • Average FCF Margin over 5 years is 608.34%, with a median of 646.92% recorded in 2025.
  • Peak YoY movement for FCF Margin: tumbled -263865bps in 2021, then soared 89245bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 718.88% in 2021, then skyrocketed by 47bps to 378.06% in 2022, then tumbled by -135bps to 887.99% in 2023, then skyrocketed by 70bps to 263.32% in 2024, then soared by 84bps to 41.54% in 2025.
  • Per Business Quant, the three most recent readings for BCYC's FCF Margin are 41.54% (Q4 2025), 612.3% (Q3 2025), and 2509.73% (Q2 2025).